Clario is a leading healthcare research and technology company that generates high-quality clinical evidence for pharmaceutical, biotechnology, and medical device partners. Formerly known as ERT and Bioclinica, Clario brings over 50 years of expertise to clinical trial management. The company fuses deep scientific knowledge with global scale to deliver the broadest endpoint technology platform available. Clario has supported nearly 900 regulatory approvals across 19,000 studies spanning almost 600 indications, demonstrating a proven track record of accelerating drug development and reducing trial risk.
Clario's comprehensive solutions span cardiac safety, electronic clinical outcome assessments (eCOA), medical imaging, precision motion, respiratory endpoints, and clinical adjudication. The company supports decentralized, hybrid, and site-based trials with advanced cloud-native technologies and AI-powered tools. With a presence in more than 80,000 sites worldwide, Clario's science-informed approach ensures the richest evidence possible for life-changing therapies. Their mission is to transform lives by unlocking better evidence, uniting clinical science, innovative technology, and global expertise to bring new treatments to patients faster.